Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood safety, has entered into a collaboration agreement with the Nipro Corporation’s pharmaceutical division to develop technology to support commercial implementation of the INTERCEPT System for Red Blood Cells (RBCs). Under the agreement, the companies will leverage Nipro’s proprietary technology to develop a set that enables the mixing and delivery of key chemical compounds to the red cell component, a process which is integral to the pathogen inactivation technology for RBCs. Cerus Corporation (NASDAQ:CERS) stock opened at $4.48 in last session, and closed at $3.84, while the day range of CERS stock is $3.74 – $4.48. The stock showed a negative weekly performance of -11.32%.
AMN Healthcare Services, Inc. (NYSE:AHS), healthcare’s innovator in workforce solutions and staffing services, announced first quarter 2014 financial results reflecting improved margins on lower than anticipated revenue. AMN Healthcare Services, Inc. (NYSE:AHS) stock opened at $11.35, in last session and closed at $11.25, by losing -10.71%. The 52 week range of AHS is $11.00 – $11.35. Company’s market capitalization is $521.98million.
Muneer Satter, Co-Chairman and Lead Director at biotherapeutic company Vital Therapies Inc (NASDAQ:VTL), bought 360,966 shares of company stock for $4,331,592. Vital Therapies Inc (NASDAQ:VTL) stock decreased -9.23% and finished the last session at $11.21. The EPS of the stock remained -3.91-. Company’s market capitalization is $236.76billion.
Alachua-based AxoGen, Inc. (NASDAQ:AXGN) reported its first quarterly sales of more than $3 million, with $3.14 million in revenues for the first quarter of 2014, a 46 percent increase over $2.14 million in the same period of 2013. AxoGen, Inc. (NASDAQ:AXGN) makes and markets products to repair peripheral nerve damage in the U.S., Canada and Europe. The company trades on the Nasdaq stock exchange under the symbol AXGN. AxoGen, Inc. (NASDAQ:AXGN) stock opened the session at $2.70, and closed the session at $2.46. The 52 week range of the AXGN stock remained $2.42 – $5.20 and the day range was $2.42 – $2.70.